Almay Clear Complexion Pressed Powder

Description

Almay Clear Complexion Pressed Powder is presented in a dosage form of a pressed powder, with a net weight of 0.28 ounces (8.0 grams). This product is designed to provide a clear complexion through its formulation.

Uses and Indications

This drug is indicated for the clearance and prevention of blemishes.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be covered with a thin layer of the medication one to three times daily. It is important to ensure that the application is uniform and that the entire affected area is adequately treated. Healthcare professionals should instruct patients on the importance of adhering to the recommended frequency to achieve optimal therapeutic outcomes.

Contraindications

Use of this product is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In such cases, it is recommended to limit the use to one topical acne medication at a time to minimize the risk of irritation.

Contact with the eyes should be strictly avoided. In the event of accidental contact, patients should be instructed to flush the eyes thoroughly with water to mitigate any potential adverse effects.

This product should be kept out of reach of children. In the case of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this medication should be aware that it is intended for external use only. The use of this product in conjunction with other topical acne medications may lead to skin irritation and dryness. In the event that irritation occurs, it is recommended that patients use only one topical acne medication at a time to minimize adverse effects.

Additionally, care should be taken to avoid contact with the eyes. Should contact occur, it is advised to flush the eyes thoroughly with water to alleviate any potential discomfort.

Drug Interactions

Concurrent use of topical acne medications may lead to skin irritation and dryness. It is advisable to limit the use to one topical acne medication at a time to minimize the risk of these adverse effects. If irritation occurs, the patient should discontinue the use of additional topical agents and focus on a single treatment to manage their acne effectively. Monitoring for signs of skin irritation is recommended when initiating or adjusting therapy.

Packaging & NDC

Below are the non-prescription pack sizes of Almay Clear Complexion Pressed Powder (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Almay Clear Complexion Pressed Powder in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this product in the geriatric population, as individual patient factors may influence safety and efficacy. Monitoring for any adverse effects is advisable when this product is used in elderly patients.

Pregnancy

There is currently no information available regarding the use of Almay Clear Complexion Pressed Powder during pregnancy. This includes any safety concerns, dosage modifications, or special precautions that may be necessary for pregnant patients. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks and benefits of using this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of antidotes or specific treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This precaution is vital to ensure the safety and well-being of children who may inadvertently access the medication.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at room temperature to maintain its efficacy and stability.

To ensure safety, the product should be kept out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately. Special handling precautions should be observed to prevent misuse and ensure the product's integrity.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the entire affected area 1 to 3 times daily. Clinicians should advise patients that the product is for external use only and caution against using it concurrently with other topical acne medications, as this may lead to skin irritation and dryness. If irritation occurs, patients should limit use to one topical acne treatment at a time.

Patients are also instructed to avoid contact with the eyes; in the event of contact, they should flush the area thoroughly with water. Should bothersome dryness or peeling develop, it is recommended to reduce the frequency of application to once daily or every other day. Additionally, the product should be kept out of reach of children, and if ingested, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Almay Clear Complexion Pressed Powder, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)